MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%
Sector Heatmap
Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%
ABSI — Absci Corporation Common Stock
NasdaqAbsci Corporation Common Stock
$10.75
-0.02(-0.19%)
- O
- 10.80
- H
- 11.27
- L
- 10.55
- V
- 4.6M
⏱️ End-of-day dataAs of Oct 1, 2026
Chart
About ABSI
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
SectorNot available
IPO DateJul 22, 2021
Employees140
Stock ExchangeNasdaq
Ticker SymbolABSI
Websitehttps://www.absci.com
Key Financial Statistics
| Market Cap | $1.67B |
| P/E Ratio | N/A |
| Dividend Yield | N/A |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $1.11 - $31.53 |
| 52-Week Avg Volume | 2.10M |
| VWAP | $10.91 |
| Transactions | 38,917 |
| Total Recorded Bars | 1,305 days |